Digital therapies are proving particularly useful in pathological conditions linked to behavioural and psychological factors, such as Alzheimer’s, dementia, type II diabetes, and even serious respiratory problems. Let’s take a look at how they are made, how they work, the indications and market perspectives.
Market
Record growth in digital therapies is foreseen over the next five years
According to a Juniper Research study, the number of people using therapeutic and wellness applications will increase from 627 million in 2020 to more than 1.4 billion in 2025.
Tele-medicine, before tele- is medicine, with all that comes with it.
The systematic adoption of telemedicine cannot ignore a number of aspects that must be considered and planned. Telemedicine is not just a technology.
An appeal to the digital health community to help healthcare in the fight against Coronavirus
SaluteDigitale and Digital-health are promoting an initiative to share and make available to healthcare IT professionals, resources and tools to combat Coronavirus infection. Continue reading
In 2019, digital health continued to attract large investments in the US

In 2019, the U.S. digital health care sector recorded, according to Rock Health, investments of $7.5 billion, slightly less than the 2018 record of $8.1 billion. Continue reading
Google demos its EHR tool: the competition is now harder!
Google Health presented the Electronic Health Record (EHR) that it is developing as part of a new generation of digital clinical instruments. It represents a difficult and very demanding challenge for industry players. Continue reading
Telemedicine solutions: what future for small manufacturers?
The market for remote monitoring solutions sees the entry of large companies offering B2B solutions. What impact will this phenomenon have on a sector that until now has been the prerogative of small and medium-sized companies? Continue reading
Financing of digital healthcare companies slows down in third quarter

According to Rock Health, after a first half in which companies raised over $2 billion each quarter, Q3 2019 saw funding of $1.3 billion, a total of $5.5 billion since the start of the year. Continue reading
Babylon gets funding for another $550 million!
Babylon announced a record investment of $550 million, bringing the company’s value to over $2 billion, to fund the development of new solutions for the treatment of chronic diseases and international expansion in the United States and Asia. Continue reading
Investors’ interest in digital health continued in the second quarter of 2019
In the first half of the year, digital health startups raised a total of $4.2 billion in 180 transactions. Continue reading